Early Percutaneous Tracheostomy for Cardiac Surgery (ETOC)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a phase III clinical trial comparing early tracheostomy (day 4) versus prolonged endotracheal intubation in ICU patients needing prolonged ventilatory support after cardiovascular surgery.
| Condition | Intervention | Phase |
|---|---|---|
|
Respiratory Failure Cardiovascular Surgery |
Procedure: Dilatational Percutaneous tracheostomy |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Evaluation of Early Percutaneous Tracheostomy in Patients Undergoing Cardiovascular Surgery and Requiring Prolonged Mechanical Ventilation |
- Number of ventilator-free days defined as the number of days between successful weaning from MV and day 60 after study enrolment. [ Time Frame: between successful weaning from MV and day 60 after study enrolment. ] [ Designated as safety issue: Yes ]
- VFDs = 0 if the patient dies before 60days. [ Time Frame: before 60 days ] [ Designated as safety issue: Yes ]
- VFDs= (60- X) : if the patient is successfully weaned from MV within 60 days, where X is the number of days spent receiving MV [ Time Frame: during 60 days ] [ Designated as safety issue: Yes ]
- VFDs = 0: if the patient requires MV for 60 days or more [ Time Frame: during 60 days and after ] [ Designated as safety issue: Yes ]
- The trial will be considered positive if early tracheostomy increases the number VFDs of at least 7 days (mean) [ Time Frame: at 7 days ] [ Designated as safety issue: Yes ]
- Other outcomes will be compared between the two arms: [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Mortality rate (day 60, in-ICU, in-hospital) [ Time Frame: during the 60 days ] [ Designated as safety issue: Yes ]
- ICU length of stay [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Hospital length of stay [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Duration of MV in survivors [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Organ failure evolution [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Infectious complications [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Early laryngeal and tracheal complications [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Sedation needs [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Patient comfort [ Time Frame: during the trial ] [ Designated as safety issue: Yes ]
- Outcome on day 90 [ Time Frame: to 90 days ] [ Designated as safety issue: Yes ]
| Enrollment: | 212 |
| Study Start Date: | July 2006 |
| Study Completion Date: | June 2009 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Dilatational Percutaneous tracheostomy
Dilatational Percutaneous tracheostomy
|
Procedure: Dilatational Percutaneous tracheostomy
Dilatational Percutaneous tracheostomy
Other Name: Dilatational Percutaneous tracheostomy
|
Detailed Description:
Background: Prolonged mechanical ventilation (MV> 7 days) is required in less than 10% of patients after cardiovascular surgery but it is associated with high morbidity and mortality.
Several studies conducted in critically ill patients suggested that early percutaneous tracheotomy compared with delayed tracheotomy decreases the length of ventilator dependence and improves outcome. To date, no randomized trial has tested these possible benefits in critically ill patients after cardiac surgery.
Study objectives: A randomized trial has been designed to determine whether early tracheostomy (day 4 after cardiac surgery) in patients still on MV would reduce the number of days under MV, measured by the evaluation of ventilator-free days (VFDs). Secondary objectives are the reduction of mortality, reduction of ICU and hospital length of stay. Evaluation of organ failure evolution, infectious complications, sedation needs, patient comfort and outcome at 3 months will be also considered.
Study hypothesis: The trial will be consider positive if early tracheotomy increases the number VFDs of at least 7 days (mean) evaluated on day 60 after randomisation.
Methods :
Trial : randomized, open, controlled, monocentric Inclusion criteria: see columns below Exclusion criteria: see columns below Randomization: will use a computerised system on day 4 after cardiac surgery Procedures: see columns below Recorded data: demographic characteristics, pre, per and postoperative parameters.
From randomization until ICU discharge (or day 60), a daily chart will be completed.
Judgment criteria: see columns below Sample size and statistical analysis: using Wilcoxon bilateral test with an alpha risk of 5% and a power of 80%, we calculated that 108 patients in each arm would be needed.
Statistical analyses will use standard tests to compare population of the two arms.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Are 18 years of age or older
- Have undergone cardiovascular surgery
- Are still on invasive mechanical ventilation on day 4 after surgery
- Have failed the screening test or the spontaneous breathing trial
- Have signed the informed consent (patient or legal representative)
Exclusion Criteria:
- Age less than18
- Pregnant woman
- Intubation more than 48 hours before cardiovascular surgery
- More than 5 days on mechanical ventilation after cardiac surgery
- Artificial heart implantation
- Concomitant neck surgery (carotid)
- Previously tracheostomized
- Major hemorrhagic risk
- Persistence of platelet count less than 50.000/mm3 after platelet transfusion
- Prothrombin time less than 30% despite coagulation factors administration
- Clinical evidence of ongoing infection at the proposed tracheotomy site
- Anatomical deformity of the neck making risky a tracheostomy
- Probability of dying the day of randomization defined by SAPSII more than 80
- Irreversible neurological lesions
- Decision of care limitation
- Prior inclusion in a trial with morbidity-mortality as main judgement criteria
- Previous enrollment in this trial
- Consent refusal
Contacts and Locations| France | |
| Institut de Cardiologie - Chu Pitie Salpetriere Ap-Hp | |
| Paris, France, 75013 | |
| Principal Investigator: | Jean Louis TROUILLET, MD, | Assistance Publique - Hôpitaux de Paris |
More Information
No publications provided by Assistance Publique - Hôpitaux de Paris
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Christophe AUCAN, Department Clinical Research of Developpement |
| ClinicalTrials.gov Identifier: | NCT00347321 History of Changes |
| Other Study ID Numbers: | P051013 |
| Study First Received: | June 29, 2006 |
| Last Updated: | December 2, 2009 |
| Health Authority: | France: Ministry of Health |
Keywords provided by Assistance Publique - Hôpitaux de Paris:
|
Percutaneous tracheostomy Endotracheal intubation Mechanical ventilation Cardiac surgery Ventilator-free days |
Additional relevant MeSH terms:
|
Respiratory Insufficiency Respiration Disorders Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 21, 2013